KIR3DL2/CD158k Antibody (539304)

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

KIR3DL2 (3DL2, p140, CD158k) is a type I transmembrane protein of the p70 family of killer cell Ig-like receptors (KIR). KIR are expressed on CD56^dim NK cells and T cell subsets where they participate in identifying normal and abnormal cells and regulating effector functions of the innate immune system (1-4). KIR are named for the number of Ig-like domains (2D or 3D) in the extracellular domain (ECD) and whether they have long or short (L, S) cytoplasmic tails. Like other inhibitory KIR, KIR3DL2 has two ITIM domains within its long tail (3). KIR3DL2 is diverse, with twelve alleles identified and as many as five single amino acid polymorphisms found in a single individual (4-6). Unlike most other KIR, gene transcripts of KIR3DL2 are expressed by all individuals (4). KIR3DL2 is present on the cell surface as a disulfide-linked homodimer of 70 kDa, 434 aa subunits (4). KIR3DL2 has shown peptide-specific binding to some HLA-A antigens, including A3 and A11 (4, 7, 8).  It also binds the abnormally folded HLA-B27 homodimer found in spondylarthritides, but not the normal heterodimer of HLA-B27 with beta 2‑microglobulin (9, 10). NK and CD4⁺ T cells from patients with spondylarthritides show increased KIR3DL2⁺ expression and may play a role in disease pathology (10). KIR3DL2 is also a marker for atypical mononuclear (Sezary) cells in the blood of patients with Sezary syndrome, an erythrodermic form of cutaneous T cell lymphoma (11). Human KIR3DL2 ECD shows 88-92% aa identity to KIR3DL2 of other primates. KIR receptors have no structural orthologs in non-primates, although mouse Ly-49 proteins are functional orthologs (3). KIR are highly related. The closest relative, KIR3DL1 shows 86% aa identity with KIR3DL2 within the ECD.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 3 applications: Depletion, Flow Cytometry, Neutralization.

Showing Publications 1 - 3 of 3.

Publications using MAB2878	Applications	Species
JL Pugh, N Nemat-Gorg, PJ Norman, LA Guethlein, P Parham Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage J. Immunol., 2017-12-20;0(0):. 2017-12-20 [PMID: 29263215] (Depletion, Flow Cytometry, Human)	Depletion, Flow Cytometry	Human
XH Zhang, XD Lian, ZX Dai, HY Zheng, X Chen, YT Zheng ?3-Deletion Isoform of HLA-A11 Modulates Cytotoxicity of NK Cells: Correlations with HIV-1 Infection of Cells J. Immunol., 2017-08-07;0(0):. 2017-08-07 [PMID: 28784847] (Neutralization, Human)	Neutralization	Human
Dunmire S, Grimm J, Schmeling D, Balfour H, Hogquist K The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events. PLoS Pathog, 2015-12-01;11(12):e1005286. 2015-12-01 [PMID: 26624012] (Flow Cytometry, Human)	Flow Cytometry	Human

Array MAB2878

• KIR3DL2/CD158k Antibodies
• KIR3DL2/CD158k Lysate